Todd C. Girolamo's most recent trade in ProKidney Corp - Ordinary Shares - Class A was a trade of 650,000 Employee stock option (right to buy) done . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 650,000 | 650,000 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | 31 Jul 2024 | 81,928 | 163,857 | - | - | Common Units in ProKidney LP | ||
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | 31 Jul 2024 | 81,928 | 163,857 | - | - | Class B Ordinary Shares | ||
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | 31 Jul 2024 | 81,928 | 163,856 | - | 0 | Class A Ordinary Shares | ||
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 300,000 | 300,000 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 234,742 | 234,742 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | C. Girolamo Todd | Chief Legal Officer | 05 Feb 2024 | 81,928 | 81,928 | - | 0 | Class A Ordinary Shares | ||
| ProKidney Corp - Ordinary ... | Todd Girolamo C. | Chief Legal Officer | 05 Feb 2024 | 81,928 | 245,785 | - | - | Common Units in ProKidney LP | ||
| ProKidney Corp - Ordinary ... | Todd Girolamo C. | Chief Legal Officer | 05 Feb 2024 | 81,928 | 245,785 | - | - | Class B Ordinary Shares | ||
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 290,000 | 290,000 | - | - | Employee stock option (right to buy) | |
| Longeveron Inc - Ordinary ... | Todd C. Girolamo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to buy) | |
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2022 | 696,793 | 696,793 | - | - | Employee stock option (right to buy) | |
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 327,713 | 327,713 | - | - | Common Units in ProKidney LP | |
| ProKidney Corp - Ordinary ... | Todd C. Girolamo | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 327,713 | 327,713 | - | - | Class B Ordinary Shares | |
| Lisata Therapeutics Inc | Todd C. Girolamo | CLO, SVP of Corp Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.81 per share. | 13 Jan 2022 | 2,563 | 162,985 (1%) | 0% | 0.8 | 2,067 | Common Stock |
| Lisata Therapeutics Inc | Todd C. Girolamo | CLO, SVP of Corp Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.82 per share. | 13 Jan 2022 | 2,158 | 160,827 (1%) | 0% | 0.8 | 1,770 | Common Stock |
| Lisata Therapeutics Inc | Todd C. Girolamo | CLO, SVP of Corp Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 129,000 | 187,675 (1%) | 1% | 0 | Common Stock | |
| Lisata Therapeutics Inc | Todd C. Girolamo | CLO, SVP of Corp Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Lisata Therapeutics Inc | Todd C. Girolamo | CLO, SVP of Corp Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 10 Jan 2022 | 17,405 | 170,270 (1%) | 0% | 0.9 | 15,960 | Common Stock |
| Lisata Therapeutics Inc | Todd C. Girolamo | CLO, SVP of Corp Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.87 per share. | 10 Jan 2022 | 4,722 | 165,548 (1%) | 0% | 0.9 | 4,085 | Common Stock |